Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year.
Sadun
Alfredo A
AA
Wang
Michelle Y
MY
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D001766:Blindness / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D054796:Drug Dosage Calculations; D004977:Ethambutol / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics; D005919:Glomerular Filtration Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008657:Metabolic Clearance Rate / Q000187:drug effects / Q000502:physiology; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009901:Optic Nerve Diseases / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D012307:Risk Factors; D014855:Wallerian Degeneration / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology
D000995:Antitubercular Agents; D004977:Ethambutol; D000255:Adenosine Triphosphate